| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +19.56% | -2.31% | +21.87% | +21.87% | — |
| 14d | 1 | +0.00% | +57.51% | -1.86% | +59.38% | +59.38% | — |
| 30d | 1 | +0.00% | +41.66% | +0.90% | +40.76% | +40.76% | — |
| 60d | 1 | +0.00% | +39.78% | +1.85% | +37.93% | +37.93% | — |
| 90d | 1 | +0.00% | +46.91% | +1.84% | +45.07% | +45.07% | — |
| 180d | 1 | +0.00% | +31.88% | +8.24% | +23.63% | +23.63% | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| SEPN SEPTERNA, INC. | SALE SVP, Drug Discovery | 3,333 | — | — | 7,043 | Jul 1, 2026 | Jul 2, 2026 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASE SVP, Drug Discovery | 3,333 | $2.76 | $9.2K | 99,745 | Jul 1, 2026 | Jul 2, 2026 ↗ | View → |
| SEPN SEPTERNA, INC. | SALE10b5-1 10b5-1 plan | 2,100 | $34.10 | $71.6K | 97,645 | Jul 1, 2026 | Jul 2, 2026 ↗ | View → |
| SEPN SEPTERNA, INC. | SALE10b5-1 10b5-1 plan | 1,233 | $34.81 | $42.9K | 96,412 | Jul 1, 2026 | Jul 2, 2026 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASE SVP, Drug Discovery | 10,529 | $2.76 | $29.1K | 106,941 | Jun 22, 2026 | Jun 24, 2026 ↗ | View → |
| SEPN SEPTERNA, INC. | SALE SVP, Drug Discovery | 4,471 | — | — | 25,529 | Jun 22, 2026 | Jun 24, 2026 ↗ | View → |
| SEPN SEPTERNA, INC. | SALE10b5-1 10b5-1 plan | 7,000 | $35.97 | $251.8K | 96,412 | Jun 22, 2026 | Jun 24, 2026 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASE SVP, Drug Discovery | 4,471 | $11.70 | $52.3K | 111,412 | Jun 22, 2026 | Jun 24, 2026 ↗ | View → |
| SEPN SEPTERNA, INC. | SALE SVP, Drug Discovery | 10,529 | — | — | 10,376 | Jun 22, 2026 | Jun 24, 2026 ↗ | View → |
| SEPN SEPTERNA, INC. | SALE10b5-1 10b5-1 plan | 8,000 | $35.10 | $280.8K | 103,412 | Jun 22, 2026 | Jun 24, 2026 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Feb 6, 2026 | Feb 10, 2026 ↗ | View → |
| SEPN SEPTERNA, INC. | SALE SVP, Drug Discovery | 3,501 | $18.06 | $63.2K | 92,911 | Nov 10, 2025 | Nov 13, 2025 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Aug 7, 2025 | Aug 11, 2025 ↗ | View → |